5Paisa Capital Limited has informed the Exchange regarding Board meeting held on May 01, 2025.
5PAISA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
5Paisa Capital Limited's board, at its meeting on May 1, 2025, approved audited financial results for Q4 and FY25 (both standalone and consolidated), reporting an unmodified audit opinion. On a consolidated basis, FY25 revenue from operations fell to ₹359.57 crore from ₹394.57 crore, but profit before tax rose to ₹91.22 crore (from ₹72.13 crore) and net profit rose about 25% to ₹68.23 crore (from ₹54.44 crore). Basic EPS for FY25 stood at ₹21.86 versus ₹17.65 in FY24. For Q4 FY25 alone, net profit was ₹10.07 crore (vs ₹5.78 crore in Q4 FY24). The board also approved the re-appointment of Mr. Ravindra Babu Garikipati as an Independent Director effective September 3, 2025, and proposed raising up to ₹250 crore through secured or unsecured redeemable non-convertible debentures on a private placement basis, subject to shareholder approval. New internal auditors (M/s. A N S A & Associates LLP) and secretarial auditors (M/s. Nilesh Shah & Associates, for 5 years from FY26 to FY30) were also appointed.
Despite a year-on-year decline in revenue, profitability improved meaningfully, which may be viewed positively by investors. The proposed ₹250 crore NCD raise could lead to some dilution of returns for existing shareholders but provides growth capital. Investors should also note an ongoing Income Tax search (January 2025) with outcome still pending and a ₹2.59 crore MCX penalty under appeal at SAT, both flagged as emphasis-of-matter items.